XML 83 R73.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity - RSUs and Revest Shares (Narrative) (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2020
cofounder
shares
Dec. 31, 2021
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   $ 35,713,000 $ 39,378,000 $ 100,856,000 $ 114,378,000    
Signal Sciences Corp.              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares restricted for stock awards (in shares) | shares           896,499  
Number of cofounders with shares subject to revesting | cofounder           3  
Shares held back for restricted stock awards, revesting period           2 years  
RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   28,700,000 27,800,000 $ 79,700,000 72,900,000    
RSUs | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period       3 years      
RSUs | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period       4 years      
RSUs | First Year | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period       3 years      
Award vesting percentage       25.00%      
RSUs | First Year | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period       4 years      
Award vesting percentage       33.00%      
RSUs | Remaining Period | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period       24 months      
RSUs | Remaining Period | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period       36 months      
Revest Shares              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   $ 0 7,300,000 $ 0 27,600,000    
Nonvested shares sold that remain unvested (in shares) | shares             224,124
Proceeds from nonvested shares sold $ 10,700,000            
Modification expense, incremental fair value     $ 0   $ 5,600,000